Morphologic leukemia-free state after venetoclax-based therapy in acute myeloid leukemia is associated with high relapse despite preserved short-term survival. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 18, n. 1, p. e2026048, 2026. DOI: 10.4084/MJHID.2026.048. Disponível em: https://www.mjhid.org/mjhid/article/view/6359. Acesso em: 1 may. 2026.